UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Journal of endocrinology, 2012-12, Vol.215 (3), p.403-412

2012

Volltextzugriff (PDF)

Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

The journal of clinical endocrinology and metabolism, 2008-07, Vol.93 (7), p.2454-2462

2008

Volltextzugriff (PDF)

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Clinical endocrinology (Oxford), 2013-04, Vol.78 (4), p.481-488

2013

Volltextzugriff (PDF)

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

Endocrine reviews, 2003-02, Vol.24 (1), p.28-47

2003

Volltextzugriff (PDF)

Administration of Acylated Ghrelin Reduces Insulin Sensitivity, Whereas the Combination of Acylated Plus Unacylated Ghrelin Strongly Improves Insulin Sensitivity

The journal of clinical endocrinology and metabolism, 2004-10, Vol.89 (10), p.5035-5042

2004

Volltextzugriff (PDF)

Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Primary Hepatocytes

The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.1055-1060

2005

Volltextzugriff (PDF)

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

European journal of endocrinology, 2010-08, Vol.163 (2), p.293-299

2010

Volltextzugriff (PDF)

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

The journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2452-2462

2004

Volltextzugriff (PDF)

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1303-1310

2012

Volltextzugriff (PDF)

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

Neuroendocrinology, 2010-01, Vol.92 (Suppl 1), p.111-115

2010

Volltextzugriff (PDF)

Medical Treatment of Cushing's Disease

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.425-438

2013

Volltextzugriff (PDF)

Novel insights in dopamine receptor physiology

European journal of endocrinology, 2007-04, Vol.156 Suppl 1 (suppl_1), p.S13-S21

2007

Volltextzugriff (PDF)

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

The journal of clinical endocrinology and metabolism, 2012-02, Vol.97 (2), p.455-462

2012

Volltextzugriff (PDF)

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

Diabetologia, 2012-04, Vol.55 (4), p.1186-1194

2012

Volltextzugriff (PDF)

Low Circulating Insulin-Like Growth Factor I Bioactivity in Elderly Men Is Associated with Increased Mortality

The journal of clinical endocrinology and metabolism, 2008-07, Vol.93 (7), p.2515-2522

2008

Volltextzugriff (PDF)

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

The journal of clinical endocrinology and metabolism, 2004-02, Vol.89 (2), p.638-645

2004

Volltextzugriff (PDF)

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

European journal of endocrinology, 2005-04, Vol.152 (4), p.645-654

2005

Volltextzugriff (PDF)

Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels

The journal of clinical endocrinology and metabolism, 2005-12, Vol.90 (12), p.6480-6489

2005

Volltextzugriff (PDF)

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

The journal of clinical endocrinology and metabolism, 2009-01, Vol.94 (1), p.223-230

2009

Volltextzugriff (PDF)

Somatostatin analogs in the diagnosis and treatment of cancer

Trends in Endocrinology & Metabolism, 2002-12, Vol.13 (10), p.451-457

2002

Volltextzugriff (PDF)

Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes

British journal of ophthalmology, 2004-01, Vol.88 (1), p.110-113

2004

Volltextzugriff (PDF)

Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease

Endocrinology (Philadelphia), 2008-09, Vol.149 (9), p.4357-4366

2008

Volltextzugriff (PDF)

Dopamine Receptor Expression and Function in Corticotroph Ectopic Tumors

The journal of clinical endocrinology and metabolism, 2007-01, Vol.92 (1), p.65-69

2007

Volltextzugriff (PDF)

Role of the mTOR Pathway in Normal and Tumoral Adrenal Cells

Neuroendocrinology, 2010-09, Vol.92 (Suppl 1), p.28-34

2010

Volltextzugriff (PDF)

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro

The journal of clinical endocrinology and metabolism, 2004-04, Vol.89 (4), p.1577-1585

2004

Volltextzugriff (PDF)

1 – 25 von 229

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(187)

Publikationsform

Artikel
(228)
Tagungsberichte
(1)

Sprache

Englisch
(229)
Japanisch
(41)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(195)
Science & Technology
(181)
Life Sciences & Biomedicine
(179)
Humans
(148)
Male
(96)
Female
(90)
Endocrinology & Metabolism
(88)
Fundamental And Applied Biological Sciences. Psychology
(81)
Endocrinopathies
(70)
Adult
(65)
Middle Aged
(61)
Animals
(57)
Vertebrates: Endocrinology
(57)
Pharmacology. Drug Treatments
(49)
Non Tumoral Diseases. Target Tissue Resistance. Benign Neoplasms
(35)
Aged
(34)
Rats
(30)
Tumors
(30)
Somatostatin - Analogs & Derivatives
(27)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

Administration of Acylated Ghrelin Reduces Insulin Sensitivity, Whereas the Combination of Acylated Plus Unacylated Ghrelin Strongly Improves Insulin Sensitivity

Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Primary Hepatocytes

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

Medical Treatment of Cushing's Disease

Novel insights in dopamine receptor physiology

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

Low Circulating Insulin-Like Growth Factor I Bioactivity in Elderly Men Is Associated with Increased Mortality

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

Somatostatin analogs in the diagnosis and treatment of cancer

Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes

Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease

Dopamine Receptor Expression and Function in Corticotroph Ectopic Tumors

Role of the mTOR Pathway in Normal and Tumoral Adrenal Cells

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro

Aktive Filter

Suchergebnisse filtern